Search research articles
Contact Us
Filters
Showing results (51-60 of 97) with videos related to
Page
of 10
Sort By:
Synapse (New York, N.Y.)
|
October 14, 2003
Amygdaloid D1 receptors are not linked to stimulation of adenylate cyclase
Sarah K Leonard, Carl M Anderson, Jean E Lachowicz, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 13, 2015
Quantitative susceptibility mapping of the midbrain in Parkinson's disease
Guangwei Du, Tian Liu, Mechelle M Lewis, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
August 6, 2005
Neurochemical effects of chronic dietary and repeated high-level acute exposure to chlorpyrifos in rats
Stephanie Padilla, Renée S Marshall, Deborah L Hunter, et al.
Neuropharmacology
|
October 28, 2006
Functional selectivity of dopamine D1 receptor agonists in regulating the fate of internalized receptors
Jessica P Ryman-Rasmussen, Adam Griffith, Scott Oloff, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 4, 2017
Statins may facilitate Parkinson's disease: Insight gained from a large, national claims database
Guodong Liu, Nicholas W Sterling, Lan Kong, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 15, 2018
Distinct progression pattern of susceptibility MRI in the substantia nigra of Parkinson's patients
Guangwei Du, Mechelle M Lewis, Christopher Sica, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 13, 2018
Characterization of the Neurochemical and Behavioral Effects of Solriamfetol (JZP-110), a Selective Dopamine and Norepinephrine Reuptake Inhibitor
Michelle G Baladi, Michael J Forster, Michael B Gatch, et al.
Bioorganic & Medicinal Chemistry
|
March 17, 2004
8,9-dihydroxy-1,2,3,11b-tetrahydrochromeno[4,3,2,-de]isoquinoline (dinoxyline), a high affinity and potent agonist at all dopamine receptor isoforms
Russell A Grubbs, Mechelle M Lewis, Connie Owens-Vance, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
January 11, 2019
Higher Hippocampal Mean Diffusivity Values in Asymptomatic Welders
Eun-Young Lee, Michael R Flynn, Guangwei Du, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 26, 2022
Dynamics of Nigral Iron Accumulation in Parkinson's Disease: From Diagnosis to Late Stage
Guangwei Du, Ernest Wang, Christopher Sica, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 97) with videos related to
Sort By:
Page
of 10
Synapse (New York, N.Y.)
|
October 14, 2003
Amygdaloid D1 receptors are not linked to stimulation of adenylate cyclase
Sarah K Leonard, Carl M Anderson, Jean E Lachowicz, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 13, 2015
Quantitative susceptibility mapping of the midbrain in Parkinson's disease
Guangwei Du, Tian Liu, Mechelle M Lewis, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
August 6, 2005
Neurochemical effects of chronic dietary and repeated high-level acute exposure to chlorpyrifos in rats
Stephanie Padilla, Renée S Marshall, Deborah L Hunter, et al.
Neuropharmacology
|
October 28, 2006
Functional selectivity of dopamine D1 receptor agonists in regulating the fate of internalized receptors
Jessica P Ryman-Rasmussen, Adam Griffith, Scott Oloff, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 4, 2017
Statins may facilitate Parkinson's disease: Insight gained from a large, national claims database
Guodong Liu, Nicholas W Sterling, Lan Kong, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 15, 2018
Distinct progression pattern of susceptibility MRI in the substantia nigra of Parkinson's patients
Guangwei Du, Mechelle M Lewis, Christopher Sica, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 13, 2018
Characterization of the Neurochemical and Behavioral Effects of Solriamfetol (JZP-110), a Selective Dopamine and Norepinephrine Reuptake Inhibitor
Michelle G Baladi, Michael J Forster, Michael B Gatch, et al.
Bioorganic & Medicinal Chemistry
|
March 17, 2004
8,9-dihydroxy-1,2,3,11b-tetrahydrochromeno[4,3,2,-de]isoquinoline (dinoxyline), a high affinity and potent agonist at all dopamine receptor isoforms
Russell A Grubbs, Mechelle M Lewis, Connie Owens-Vance, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
January 11, 2019
Higher Hippocampal Mean Diffusivity Values in Asymptomatic Welders
Eun-Young Lee, Michael R Flynn, Guangwei Du, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 26, 2022
Dynamics of Nigral Iron Accumulation in Parkinson's Disease: From Diagnosis to Late Stage
Guangwei Du, Ernest Wang, Christopher Sica, et al.
Page
of 10